Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth
Stephen T. Abedon, Katarzyna Danis‐Wlodarczyk, Daniel J. Wozniak
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1019-1019
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Current Clinical Landscape and Global Potential of Bacteriophage Therapy
Nicole Hitchcock, Danielle Devequi Gomes Nunes, Job Shiach, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 1020-1020
Open Access | Times Cited: 94
Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
Aleksandra Petrović Fabijan, Jonathan R. Iredell, Katarzyna Danis‐Wlodarczyk, et al.
PLoS Biology (2023) Vol. 21, Iss. 5, pp. e3002119-e3002119
Open Access | Times Cited: 66
Developing Phage Therapy That Overcomes the Evolution of Bacterial Resistance
Agnès Oromí-Bosch, Jyot D. Antani, Paul E. Turner
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 503-524
Open Access | Times Cited: 63
Genetically Engineered Microorganisms and Their Impact on Human Health
Marzie Mahdizade Ari, Leila Dadgar, Z Yad Elahi, et al.
International Journal of Clinical Practice (2024) Vol. 2024, pp. 1-38
Open Access | Times Cited: 23
Prediction of strain level phage–host interactions across the Escherichia genus using only genomic information
Baptiste Gaborieau, Hugo Vaysset, Florian Tesson, et al.
Nature Microbiology (2024) Vol. 9, Iss. 11, pp. 2847-2861
Closed Access | Times Cited: 21
Critically evaluating the relative importance of phage in shaping microbial community composition
Meaghan Castledine, Angus Buckling
Trends in Microbiology (2024) Vol. 32, Iss. 10, pp. 957-969
Open Access | Times Cited: 18
Staphylococcal Drug Resistance: Mechanisms, Therapies, and Nanoparticle Interventions
Kunyu Shao, Yihong Yang, Xiaobao Gong, et al.
Infection and Drug Resistance (2025) Vol. Volume 18, pp. 1007-1033
Open Access | Times Cited: 2
Biological foundations of successful bacteriophage therapy
Carola Venturini, Aleksandra Petrović Fabijan, Alicia Fajardo Lubián, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 7
Open Access | Times Cited: 64
Enhancing bacteriophage therapeutics through in situ production and release of heterologous antimicrobial effectors
Jiemin Du, Susanne Meile, Jasmin Baggenstos, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
The Biotechnological Application of Bacteriophages: What to Do and Where to Go in the Middle of the Post-Antibiotic Era
Su Jin Jo, Jun Kwon, Sang Guen Kim, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2311-2311
Open Access | Times Cited: 25
Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
Hamideh Raeisi, Maryam Noori, Masoumeh Azimirad, et al.
Gut Pathogens (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Phage therapy: an alternative treatment modality for MDR bacterial infections
Namrata Pal, Poonam Sharma, Manoj Kumawat, et al.
Infectious Diseases (2024) Vol. 56, Iss. 10, pp. 785-817
Closed Access | Times Cited: 10
Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs
Fabian Kunisch, Claudia Campobasso, Jeroen Wagemans, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections
Minyoung Kevin Kim, Qingquan Chen, Arne Echterhof, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches
Minyoung Kevin Kim, Gina A. Suh, Grace Cullen, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 5
Open Access | Times Cited: 1
Fitness Trade-Offs in Phage Cocktail-Resistant Salmonella enterica Serovar Enteritidis Results in Increased Antibiotic Susceptibility and Reduced Virulence
Dongyang Gao, Hongyue Ji, Linkang Wang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 36
Flagellotropic Bacteriophages: Opportunities and Challenges for Antimicrobial Applications
Nathaniel C. Esteves, Birgit E. Scharf
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7084-7084
Open Access | Times Cited: 32
Design of Phage-Cocktail–Containing Hydrogel for the Treatment of Pseudomonas aeruginosa–Infected Wounds
Fatemeh Shafigh Kheljan, Farzam Sheikhzadeh Hesari, Mohammad Sadegh Amini‐Fazl, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 803-803
Open Access | Times Cited: 21
Natural Killers: Opportunities and Challenges for the Use of Bacteriophages in Microbial Food Safety from the One Health Perspective
María Lavilla, Pilar Domingo‐Calap, Sandra Sevilla‐Navarro, et al.
Foods (2023) Vol. 12, Iss. 3, pp. 552-552
Open Access | Times Cited: 18
Fighting Salmonella Infantis: bacteriophage-driven cleaning and disinfection strategies for broiler farms
Sandra Sevilla‐Navarro, Jan Torres-Boncompte, Josep Garcia-Llorens, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 8
Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant Acinetobacter baumannii
Yoon-Jung Choi, Shukho Kim, Minsang Shin, et al.
Antibiotics (2024) Vol. 13, Iss. 7, pp. 610-610
Open Access | Times Cited: 8
The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae
Omid Gholizadeh, Hadi Esmaeili Gouvarchin Ghaleh, Mahdi Tat, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Uses of Bacteriophages as Bacterial Control Tools and Environmental Safety Indicators
Paula Rogovski, Rafael Dorighello Cadamuro, Raphael da Silva, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 38
Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens
Tahir Farooq, Muhammad Dilshad Hussain, Muhammad Taimoor Shakeel, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 171-171
Open Access | Times Cited: 27
Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review
Fatemeh Zeynali Kelishomi, Susan Khanjani, Fatemeh Fardsanei, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top